Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
exn407 (1 trial)
nicotinamide (1 trial)
Macular Edema (Phase 2)
Trials (2 total)
Trial APIs (2 total)